PD-MitoQUANT researcher Dr. Orla Watters from the Royal College of Surgeons in Ireland presented a poster entitled: The effects of local energetic stress on mitochondrial transport in primary cortical axons at the Society for Neuroscience (SfN) 2019 conference in Chicago, IL, USA. Other authors contributing to the study poster were N. M. C. Connolly, H-G. König, H. Düssmann, and J. H. M. Prehn. The poster was presented on Saturday, the 19th of October at 13:00-17:00 poster session. Download the pdf of the poster here. The SfN meeting took place from October 19th - 23rd. The Society for Neuroscience is the world’s largest organization of scientists and physicians devoted to understanding the brain and the nervous system.
Researchers looking for a brief snapshot of PD-MitoQUANT to insert into their presentations need to look no further! With distinct audiences in mind, we have created two brief slide decks to describe the work undertaken in PD-MitoQUANT and to acknowledge all partners in and funders of the project. Download the slides for scientific presentations here. Download the slides for a general public audience here.
PD-MitoQUANT is one of twelve research projects launched by the Innovative Medicines Initiative, Europe's biggest public and private collaboration in life sciences, which aim to better understand and develop treatments for neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. PD-MitoQUANT has joined forces with these research projects on the Neuronet platform to aid progress and expedite the delivery of novel treatments. A memorandum of understanding was jointly signed by Coordinator Prof Jochen Prehn, RCSI and Carlos Díaz, Coordinator of Neuronet on October 9, 2019. Neuronet aims to help scientists identify gaps in research, make findings more visible for society as a whole and create links between Innovative Medicines Initiative projects and other international research initiatives. Learn more about the Neuronet project here: https://www.imi-neuronet.org/
In October 2020, PD-MitoQUANT PI Dr Ronald Melki, CNRS is co-chairing the Jacques Monod conference which is themed: Protein phase transitions in ageing and age-related diseases: from atomic resolution to cellular solutions. Several PD-MitoQUANT PIs will present here. Where: Roscoff (Bretagne), France When: October 12-16, 2020 REGISTRATION REQUEST and ABSTRACT SUBMISSION DEADLINE: June 12, 2020 The conference- Cells and organisms maintain protein homeostasis in several cooperating ways, which include protein folding, degradation, and sequestration. During aging, the capacity to maintain protein homeostasis declines, which leads to the accumulation of aggregation-prone proteins. These aggregation-prone proteins can accelerate aging and cause age-related diseases like Parkinson’s disease, tauopathies, Alzheimer’s, and Amyotrophic Lateral Sclerosis. How they do so is still not fully understood. Understanding the underlying mechanisms will be important for the development of therapeutic strategies. Recent groundbreaking discoveries have revealed new aspects of protein homeostatic and pathological mechanisms. These include the phenomena of protein [...]
PD-MitoQUANT PI Dr Ronald Melki of the Centre National de la Recherche Scientifique, CNRS was an invited speaker at the International Symposium on Neurodegenerative Diseases organized by the University of Texas Southwestern O’Donnell Brain Institute in Dallas, Texas and the Texas Alzheimer’s Research and Care Consortium. The meeting took place on October 24 and 25, 2019 at the T. Boone Pickens Biomedical Building, NG3.11. Ronald's talk entitled "Prion-like propagation of alpha-synuclein and Tau assemblies in synucleinopathies and tauopathies" was facilitated on October 25th. The symposium highlighted the latest advances in clinical, translational, and basic research on Alzheimer’s disease and related disorders, and featured prominent national and international speakers.